Fazhen Luo
1200 Cailun Road
Shanghai, 201203, China
Shanghai, 201203, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
A Glycyrrhiza Glabra-derived pH/ROS Dual-Responsive Phytomedicine Nanoplatform for Combatting Triple-Negative Breast Cancer via Amplified Mitochondrial Damage.
Journal: Advanced healthcare materials
Published: November 22, 2025
Kuanxin tablet, a patented herbal-based TCM formula, alleviates cardiomyocyte apoptosis via activation of PI3K/p70S6K signaling pathway in myocardial infarction rats.
Journal: Fitoterapia
Published: November 20, 2025
Mannose-modified Prunus persica kernel protein nanoparticles loading baicalin coated with Lycium barbarum polysaccharide for ulcerative colitis treatment.
Journal: Carbohydrate polymers
Published: June 04, 2025
Injectable self-healing hydrogels loaded with Crinis Carbonisatus nanoparticles for rapid hemostasis and wound healing.
Journal: Journal of materials chemistry. B
Published: May 23, 2025
Saikosaponin D potentiates the antineoplastic effects of doxorubicin in drug-resistant breast cancer through perturbing NQO1-mediated intracellular redox balance.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: April 14, 2024
Hyaluronic acid/dextran-based polymeric micelles co-delivering ursolic acid and doxorubicin to mitochondria for potentiating chemotherapy in MDR cancer.
Journal: Carbohydrate polymers
Published: November 02, 2023
Isorhamnetin induces cell cycle arrest and apoptosis by triggering DNA damage and regulating the AMPK/mTOR/p70S6K signaling pathway in doxorubicin-resistant breast cancer.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: November 20, 2022
Ursolic acid augments the chemosensitivity of drug-resistant breast cancer cells to doxorubicin by AMPK-mediated mitochondrial dysfunction.
Journal: Biochemical pharmacology
Published: July 22, 2022
A Nanosized Codelivery System Based on Intracellular Stimuli-Triggered Dual-Drug Release for Multilevel Chemotherapy Amplification in Drug-Resistant Breast Cancer.
Journal: Pharmaceutics
Published: January 16, 2022
Showing 1-9 of 9
Last Updated: 09/26/2026